Psychosocial factors, sex differences, and atherosclerosis: Lessons from animal models

Psychosomatic Medicine

Volumn 58, Issue 6, 1996, Pages 598-611

  Kaplan, Jay R ^a   Adams, Michael R ^a   Clarkson, Thomas B ^a   Manuck, Stephen B ^b   Shively, Carol A ^a   Williams, J Koudy ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; coronary heart disease; cynomolgus macaques; ovarian dysfunction; psychosocial stress; risk factors

Indexed keywords

ESTROGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ATHEROSCLEROSIS; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; HYPERCORTISOLISM; MACACA; MALE; NONHUMAN; ORAL CONTRACEPTION; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SOCIAL PSYCHOLOGY;

EID: 0029808902     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199611000-00008     Document Type: Review

References (126)

1. Sarton G: Galen of Pergamon. Lawrence, University of Kansas, 1954
2. Prichard RW: Animal models in human medicine. In: Animal Models of Thrombosis and Hemorrhagic Diseases. Proceedings of the Workshop on Animal Models of Thrombosis and Hemorrhagic Diseases, National Academy of Sciences, Washington, DC, 1975, pp 169-172 (DHEW Publication No. (NIH) 76:982)
3. Cannon WB: Bodily Changes in Pain, Hunger, Fear and Rage: An Account of Recent Researches into the Function of Emotional Excitement. New York, Appleton, 1929
4. Selye H: The Stress of Life, Revised Edition. New York, McGraw-Hill, 1976
5. Manuck SB, Marsland AL, Kaplan JR, Williams JK: The pathogenicity of behavior and its neuroendocrine mediation: An example from coronary artery disease. Psychosom Med 57:275-283, 1995
6. Folkow B: Stress, hypothalamic function and neuroendocrine consequences. Acta Med Scand 723:61-69, 1988
7. McGill HC, Stern NP: Sex and atherosclerosis. Atheroscler Rev 4:157-242, 1979
8. Moriyama IM, Krueger DE, Stamler J: Cardiovascular Diseases in the United States, Chap 4. Cambridge, MA, Harvard University Press, 1971
9. American Heart Association: 1992 Heart and Stroke Facts. Dallas, American Heart Association, 1993
10. Katz LN, Stamler J: Experimental atherosclerosis. Springfield, IL, Charles C Thomas, 1953
11. McGill HC Jr: Atherosclerosis: Problems in pathogenesis. Atheroscler Rev 2:27-65, 1977
12. Klemperer P: Franz Groedel Memorial Lecture. The history of coronary sclerosis. Am J Cardiol 1:94-107, 1960
13. McGill HC Jr: The Geographic Pathology of Atherosclerosis. Baltimore, Williams & Wilkins, 1968
14. Wolf SG: History of the study of stress and heart disease. In Beamish RE, Singal PK, Dhalla NS (eds), Stress and Heart Disease. Boston, MA, Martinus Nijhoff Publishing, 1985, 3-16.
15. Prichard RW: Introducing behavioral factors into atherosclerosis research. Am J Pathol 101(Suppl 3S):S171-S176, 1980
16. Manuck SB, Kaplan JR, Matthews KA: Behavioral antecedents of coronary heart disease and atherosclerosis. Arteriosclerosis 6:2-14, 1986
17. Higgins M, Thorn T: Cardiovascular disease in women as a public health problem. In Wenger NK, Speroff L, Packard B (eds.), Cardiovascular Health and Disease in Women. Greenwich, CT, Lejacq Communications, Inc., 1993, 15-19
18. Thom TJ: Cardiovascular disease mortality among United States women. In Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA (eds), Coronary Heart Disease in Women. New York, Haymarket Doyma, Inc., 1987, 33-41
19. Godsland IF, Wynn V, Crook D, Miller NE: Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions. Am Heart J 114:1467-1503, 1987
20. Manson JE: Postmenopausal hormone therapy and atherosclerotic disease. Am Heart J 128:1337-1343, 1994
21. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE: Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 325:756-762, 1991
22. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA: Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 115:954-963, 1988
23. Sullivan JM, Vander Zwaag R, Lemp GF, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM: Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 108:358-363, 1988
24. Oliver MF: Ischaemic heart disease in young women. Br Med J 4:253-259, 1974
25. Bengtsson C: Ischaemic heart disease in women. Acta Med Scand 549(Suppl):1-128, 1973
26. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH: Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105-1110, 1987
27. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR: Menopause and risk factors for coronary heart disease. N Engl J Med 321:641-646, 1989
28. Speroff L: The impact of oral contraception and hormone replacement therapy on cardiovascular disease. In Wenger NK, Speroff L, Packard B (eds), Cardiovascular Health and Disease in Women. Greenwich, CT, Lejacq Communications, Inc., 1993, 37-45
29. Lobo RA: Hormones, hormone replacement and heart disease. In Douglas PS (ed), Cardiovascular Health and Disease in Women. Philadelphia, Saunders, 1993, 153-173
30. LaRosa JC: Some aspects of coronary risk and prevention factors in women. In Wenger NK, Speroff L, Packard B (eds), Cardiovascular Health and Disease in Women. Greenwich, CT, Lejacq Communications, Inc., 1993, 31-35
31. Bush TL, Miller VT: Effects of pharmacologic agents used during menopause: Impact on lipids and lipoproteins. In Mishell DR (ed), Menopause: Physiology and Pharmacology. Chicago, Year Book Medical Publishers, 1987, 187-208
32. Barrett-Connor E, Wingard DL, Criqui MH: Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA 261:2095-2100, 1989
33. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM: Cardiovascular mortality and non-contraceptive estrogen use in women: Results from the Lipid Research Clinics' Program Follow-Up Study. Circulation 75:1002-1009, 1987
34. McGill HC Jr: Sex steroid hormone receptors in the cardiovascular system. Postgrad Med April:64-68, 1989
35. Godsland IF, Wynn V, Crook D, Miller NE: Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions. Am Heart J 114:1467-1503, 1987
36. Heller RF, Jacobs HS: Coronary heart disease in relation to age, sex, and the menopause. Br Med J 1:472-474, 1978
37. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 332:1589-1593, 1995
38. Ballinger S: Stress as a factor in lowered estrogen levels in the early postmenopause. Ann NY Acad Sci 592:95-112, 1990
39. Seibel MM, Taymor ML: Emotional aspects of infertility. Fertil Steril 37:137-145, 1982
40. Giles DE, Berga SL: Cognitive and psychiatric correlates of functional hypothalamic amenorrhea: A controlled comparison. Fertil Steril 60:486-492, 1993
41. Judd SJ: Pathophysiological mechanisms of stress-induced chronic anovulation. In Sheppard KE, Boublik JH, Funder JW (eds), Stress and Reproduction. New York, Raven Press, 1992, 253-265
42. Kinch RAH, Plunkett ER, Smout MS, Carr DH: Primary ovarian failure. A clinicopathological and cytogenetic study. Am J Obstet Gynecol 91:630-644, 1965
43. Russell P, Bannatyne P, Shearman RP, Fraser IS, Corbett P: Premature hypergonadotropic ovarian failure. Clinicopathological study of 19 cases. Int J Gynecol Pathol 1:185-201, 1982
44. Starup J, Sele V: Premature ovarian failure. Acta Obstet Gynecol Scand 52:259-268, 1973
45. Aiman J, Smentek C: Premature ovarian failure. Obstet Gynecol 66:9-14, 1985
46. Berga SL, Loucks AB, Rossmanith WG, Kettel LM, Laughlin GA, Yen SSC: Acceleration of luteinizing hormone pulse frequency in functional hypothalamic amenorrhea by dopaminergic blockade. J Clin Endocrinol Metab 72:151-156, 1991
47. LaVecchia C, Decardi A, Franceschi S, Gentile A, Negri E, Parazzini F: Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol 157:1108-1112, 1987
48. Schneiderman N: Psychophysiologic factors in atherogenesis and coronary artery disease. Circulation 76(Suppl I):141-147, 1987
49. Blumenthal SJ, Matthews KA: Working group report: Psychosocial aspects of cardiovascular disease in women. In NK Wenger, L Speroff, B Packard (eds), Cardiovascular Health and Disease in Women. Greenwich, CT, LeJacq Communications, Inc., 1993, 213-216
50. Wenger NK: Coronary heart disease in women: An overview (myths, misperceptions, and missed opportunities). In Wenger NK, Speroff L, Packard B (eds), Cardiovascular Health and Disease in Women. Greenwich, CT, LeJacq Communications, Inc., 1993, 21-29
51. Haynes SG, Czajkowski SM: Psychosocial and environmental correlates of heart disease. In Douglas PS (ed), Cardiovascular Health and Disease in Women. Philadelphia, Saunders, 1993, 269-282
52. Stamler J, Pick R, Katz LN: Experiences in assessing estrogen antiatherogenesis in the chick, the rabbit, and man. Ann NY Acad Sci 64:596-619, 1956
53. Prichard RW, Clarkson TB, Lofland HB: Estrogen in pigeon atherosclerosis. Estradiol valerate effects at several dose levels on cholesterol-fed male white Carneau pigeons. Arch Pathol 82:15-17, 1966
54. Prichard RW, Clarkson TB, Goodman HO, Lofland HB: Aortic atherosclerosis in pigeons and its complications. Arch Pathol 77:244-257, 1964
55. Fillios LC, Mann GV: The importance of sex in the variability of cholesteremic response of rabbits fed cholesterol. Circ Res 4:406-412, 1956
56. Ludden JB, Bruger M, Wright IS: Experimental atherosclerosis IV. Effects of testosterone propionate and estradiol dipropionate on experimental atherosclerosis in rabbits. Arch Pathol 33:58-62, 1942
57. Lorenzen I: Vascular connective tissue under the influence of oestrogens: 1. Biochemical and morphological studies of aortae of untreated female and male rabbits, and aortae of castrated and sham operated female rabbits. Acta Endocrinol (Kbh) 52:565-572, 1966
58. Haarbo J, Leth-Espensen P, Stender S, Christiansen C: Estrogen monotherapy and combined estrogen-progestogen therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 87:1274-1279, 1991
59. Haarbo J, Svendsen OL, Christiansen C: Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ Res 70:1198-1202, 1992
60. Jayo JM, Schwenke DC, Clarkson TB: Atherosclerosis research. In Manning PJ, Ringler DH, Newcomer CE (eds), The Biology of the Laboratory Rabbit, 2nd Edition. San Diego, Academic Press, 1994, 367-380
61. Kaplan JR, Manuck SB, Clarkson TB, Prichard RW: Animal models of behavioral influences on atherogenesis. Adv Behav Med 1:115-163, 1985
62. MacDonald GT: Reproductive patterns of three species of macaques. Fertil Steril 22:373-377, 1971
63. Mahoney CJ: A study of the menstrual cycle in Macaca irus with special reference to the detection of ovulation. J Reprod Fertil 21:153-163, 1970
64. Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA: Social behavior and gender in biomedical investigations using monkeys: Studies in atherogenesis. Lab Anim Sci 41:334-343, 1991
65. Clarkson TB, Williams JK, Adams MR, Wagner JD, Klein KP: Experimental effects of estrogens and progestins on the coronary artery wall. In Wenger NK, Speroff L, Packard B (eds), Cardiovascular Health and Disease in Women. Greenwich, CT, LeJacq Communications, Inc., 1993, 169-174
66. Hamm TE Jr, Kaplan JR, Clarkson TB, Bullock BC: Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis 48:221-233, 1983
67. Kaplan JR, Adams MR, Clarkson TB, Koritnik DR: Psychosocial influences on female "protection" among cynomolgus macaques. Atherosclerosis 53:283-295, 1984
68. Altmann J: Observational study of behavior: Sampling methods. Behaviour 48:1-41, 1974
69. Sade DS: An ethogram for rhesus monkeys. I. Antithetical contrasts in posture and movement. Am J Phys Anthropol 38:537-542, 1973
70. Sade DS: Determinants of dominance in a group of free ranging rhesus monkeys. In Altmann S (ed), Social Communication among Primates. Chicago, University of Chicago Press, 1967, 99-114
71. Adams MR, Kaplan JR, Koritnik DR: Psychosocial influences on ovarian endocrine and ovulatory function in Macaca fascicularis. Physiol Behav 35:935-940, 1985
72. Adams MR, Kaplan JR, Koritnik DR, Clarkson TB: Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 5:192-200, 1985
73. Adams MR, Kaplan JR, Koritnik DR, Clarkson TB: Pregnancy-associated inhibition of coronary artery atherosclerosis in monkeys. Evidence of a relationship with endogenous estrogen. Arteriosclerosis 7:378-384, 1987
74. Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB: Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Atheroscler Thromb Vasc Biol 15:2094-2100, 1995
75. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR: Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88:1995-2002, 1991
76. Wagner JD, Adams MR, Schwenke DC, Clarkson TB: Oral contraceptive therapy decreases arterial low density lipoprotein degradation in female cynomolgus monkeys. Circ Res 72:1300-1307, 1993
77. Sack MN, Rader DJ, Cannon RO: Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269-270, 1994
78. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046-1051, 1986
79. Maseri A, L'Abbate A, Bardoli G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Paradi O, Biagini A, Distante A, Pestola A: Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from the study of "preinfarction" angina. N Engl J Med 299:1271-1277, 1978
80. Maseri A, Severi S, DeNes M, L'Abbate A, Chierchia S, Marzilli M, Ballestra AM, Paradi O, Biagini A, Distante A: "Variant" angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia: Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol 42:1019-1035, 1978
81. Roberts WC, Durry RC, Isner JM: Sudden death in Prinzmetal's angina with coronary spasm documented by angiography: Analysis of three necropsy patients. Am J Cardiol 50:203-210, 1982
82. Williams JK, Adams MR, Klopfenstein HS: Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687, 1990
83. Williams JK, Adams MR, Herrington DM, Clarkson TB: Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 20:452-457, 1992
84. Williams JK, Honoré EK, Washburn SA, Clarkson TB: Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 24:1757-1761, 1994
85. Williams JK, Shively CA, Clarkson TB: Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis. Circulation 90:983-987, 1994
86. Ahmed SA, Penhale WJ, Talal N: Sex hormones, immune responses, and autoimmune diseases: Mechanisms of sex hormone action. Am J Pathol 121:531-551, 1985
87. Loy RA, Loukides JA, Polan ML: Ovarian steroids modulate human monocyte tumor necrosis factor alpha messenger ribonucleic acid levels in cultured human peripheral monocytes. Fertil Steril 58:733-739, 1992
88. Polan ML, Loukides J, Nelson P, Carding S, Diamond M, Walsh A, Bottomly K: Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab 69:1200-1206, 1989
89. Schuurs AHWM, Verheul HAM: Effects of gender and sex steroids on the immune response. J Steroid Biochem 35:157-172, 1990
90. Troxler RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ: The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 26:151-162, 1977
91. Sprague EA, Troxler RG, Peterson DF, Schmidt RE, Young JT: Effect of cortisol on the development of atherosclerosis in cynomolgus monkeys. In Kalter SS (ed), The Use of Nonhuman Primates in Cardiovascular Disease. Austin, University of Texas Press, 1980, 261-264
92. Stamler J, Pick R, Katz LN: Experiences in assessing estrogen antiatherogenesis in the chick, the rabbit, and man. Ann NY Acad Sci 64:596-619, 1956
93. Kaplan JR, Adams MR, Koritnik DR, Rose JC, Manuck SB: Adrenal responsiveness and social status in intact and ovariectomized Macaca fascicularis. Am J Primatol 11:181-193, 1986
94. Williams RB, Suarez ED, Kuhn CM, Zimmerman EA, Schanberg SM: Biobehavioral basis of coronary-prone behavior in middle-aged men. Part I: Evidence for chronic SNS activation of Type As. Psychosom Med 53:517-527, 1991
95. Kaplan JR, Pettersson K, Manuck SB, Olsson G: Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis. Circulation 84(Suppl VI): VI-23-VI-32, 1991
96. 1-adrenoceptor activation. Circ Res 67:1027-1034, 1990
97. Strawn WB, Bondjers G, Kaplan JR, Manuck SB, Schwenke DC, Hansson GK, Shively CA, Clarkson TB: Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res 68:1270-1279, 1991
98. Schwartz S, Gadusek C, Sheldon S: Vascular wall growth control: The role of endothelium. Arteriosclerosis 1:107-126, 1981
99. Manuck SB, Kaplan JR, Muldoon MF, Adams MR, Clarkson TB: The behavioral exacerbation of atherosclerosis and its inhibition by propranolol. In McCabe PM, Schneiderman N, Field TM, Skylar JS (eds), Stress, Coping and Disease. Hillsdale, NJ, Lawrence Erlbaum Associates, 1991, 51-72
100. Kaplan JR, Manuck SB, Adams MR, Weingand KW, Clarkson TB: Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 76:1364-1372, 1987
101. Manuck SB, Polefrone JM: Psychophysiologic reactivity in women. In Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA (eds), Coronary Heart Disease in Women. New York, Haymarket Doyma, Inc., 1987, 164-171
102. Owens JF, Stoney CM, Matthews KA: Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 88:2794-2802, 1993
103. Stoney CM, Davis MC, Matthews KA: Sex differences in physiological responses to stress and in coronary heart disease: A causal link? Psychophysiology 24:127-131, 1987
104. Manuck SB, Kaplan JR, Adams MR, Clarkson TB: Behaviorally elicited heart rate reactivity and atherosclerosis in female cynomolgus monkeys (Macaco fascicularis). Psychosom Med 51:306-318, 1989
105. Reid IA, Morris BJ, Ganong WF: The renin-angiotensin system. Annu Rev Physiol 40:377-410, 1978
106. Hilgers KF, Veelken R, Kreppner I, Ganten D, Luft FC, Geiger H, Mann JFE: Vascular angiotensin and the sympathetic nervous system: Do they interact? Am J Physiol 267:H187-H194, 1994
107. Dorward PK, Rudd CD: Influence of brain renin-angiotensin system on renal sympathetic and cardiac baroreflexes in conscious rabbits. Am J Physiol 260:H770-H778, 1991
108. Ganong WF: Review of Medical Physiology, 17th Edition. Norwalk, CT, Appleton & Lange, 1993
109. Aberg G, Ferrer P: Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 15(Suppl 5):S65-S72, 1990
110. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE: Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J Biol Chem 269:10935-10939, 1994
111. Rogers TB, Lokuta AJ: Angiotensin II signal transduction pathways in the cardiovascular system. Trends Cardiovasc Med 4:110-116, 1994
112. Proudler AJ, Ahmed AIH, Crook D, Fogelman I, Rymer JM, Stevenson JC: Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 346:89-90, 1995
113. Brosnihan KG, Li P, Ferrario CM: Angiotensin-(1-7) elicits nitric oxide-dependent vasodilation in canine coronary arteries [Abstract], Hypertension 26:544, 1995
114. Dittus WPJ: The evolution of behaviors regulating density and age-specific sex ratios in a primate population. Behaviour 69:265-302, 1979
115. Drickamer LC: A ten-year summary of reproductive data for free-ranging Macaca mulatta. Folia Primatol (Basel) 21:61-80, 1974
116. Sade D, Cushing K, Gushing P, Dunaif J, Figueroa A, Kaplan JR, Lauer C, Rhodes D, Schneider J: Population dynamics in relation to social structure on Cayo Santiago. Yearbook Phys Anthropol 20:253-262, 1976
117. Silk JB, Clark-Wheatley C, Rodman PS, Samuels A: Differential reproductive success and facultative adjustment of sex ratios among captive female bonnet macaques (Macaca radiata). Anim Behav 29:1106-1120, 1981
118. Walker ML, Gordon TP, Wilson ME: Menstrual cycle characteristics of seasonally breeding rhesus monkeys. Biol Reprod 29:841-848, 1983
119. Wilson ME, Gordon TP, Bernstein IS: Timing of births and reproductive success in rhesus monkey social groups. J Med Primatol 7:202-212, 1978
120. Shively CA, Kaplan JR, Adams MR: Effects of ovariectomy, social instability and social status on female Macaca fascicularis social behavior. Physiol Behav 36:1147-1153, 1986
121. Reifenstein EC Jr: Psychogenic or "hypothalamic" amenorrhea. Med Clin North Am 30:1103-1104, 1946
122. Berga SL, Girton LG: The psychoneuroendocrinology of functional hypothalamic amenorrhea. Psychiatric Clin North Am 12:105-116, 1989
123. Berga SL, Mortola JF, Girton L, Suh B, Laughlin G, Pham P, Yen SSC: Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 68:301-308, 1989
124. Biller BMK, Coughlin JF, Saxe V, Schoenfeld D, Sprat DI, Klibanski A: Osteopenia in women with hypothalamic amenorrhea: A prospective study. Obstet Gynecol 78:996-1001, 1991
125. Seeman E, Szmukler GI, Formica C, Tsalamandria C, Mestrovic R: Osteoporosis in anorexia nervosa: The influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 7:1467-1474, 1992
126. Ohkura T, Isse K, Akazawa K, Hamomoto M, Yaoi Y, Hagino N: Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 6:99-107, 1995